|
|
Volumn 91, Issue 10, 2011, Pages
|
|
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study
a,g
g
NONE
(Italy)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
CYCLOSPORIN A;
EVEROLIMUS;
HEMOGLOBIN;
PREDNISONE;
ABDOMINAL ABSCESS;
ACUTE GRAFT REJECTION;
ANEMIA;
ARTHRALGIA;
CHRONIC GRAFT REJECTION;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIASTOLIC BLOOD PRESSURE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
GLOMERULOPATHY;
GLOMERULOSCLEROSIS;
GLOMERULUS FILTRATION RATE;
GRAFT SURVIVAL;
HEART INFARCTION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERPLASIA;
IMMUNE RESPONSE;
INTERSTITIAL PNEUMONIA;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LETTER;
MAJOR CLINICAL STUDY;
MORTALITY;
MUCOSA INFLAMMATION;
PANCREATITIS;
PRIORITY JOURNAL;
PROTEINURIA;
SURVIVAL RATE;
SYSTOLIC BLOOD PRESSURE;
URINARY TRACT INFECTION;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
SIROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 79955634445
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e318216c1db Document Type: Letter |
|
Times cited : (15)
|
|
References (3)
|
